BIOMARKERS FOR PRE-SELECTION OF PATIENTS FOR ANTI-IGF1R THERAPY
摘要
The present invention provides methods for identifying patients whose cancers are likely to be responsive to IGF1R inhibitory anti-cancer therapy along with methods for treating such patients. Patients identified by a method of the present invention can be treated with any of several known IGF1R inhibitory agents including antibodies, small molecule inhibitors and anti-sense nucleic acids.
申请公布号
WO2006060419(A9)
申请公布日期
2006.07.20
申请号
WO2005US43184
申请日期
2005.11.30
申请人
SCHERING CORPORATION;WANG, YAN;PACHTER, JONATHAN;WANG, YAOLIN;LIU, MING
发明人
WANG, YAN;PACHTER, JONATHAN;WANG, YAOLIN;LIU, MING